Abstract

In finding that 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (BPHPP) produced high concentrations of blood glucose in rats, it was observed that (1) the maximum concentration of blood glucose was obtained 1 hr after oral administration at a dose of 100 mg/kg of BPHPP, (2) that BPHPP has no effect on the secretion of adrenal corticosterone, (3) that BPHPP markedly inhibited cAMP phosphodiesterase activity, in vitro, and (4) that in the preliminary experiment, the hepatic cAMP levels increased 1.7-fold by the administration (10 mg/kg) of BPHPP. From these results, it was presumed that the high concentrations of blood glucose may be the results of elevations in the intracellular cAMP levels due to the inhibitory action of BPHPP on cAMP phosphodiesterase.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.